In the process of characterizing the subset of CAFs with CXCL14 overexpression, we noticed that they were mainly clustered in the iCAF and naïve-CAF subsets, which is also consistent with reports of prostate cancer [36]. This evidence concerns the gene CXCL14 and prostate cancer.